10x Genomics (TXG) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for 10x Genomics (TXG) over the last 7 years, with Q4 2025 value amounting to -$0.13.
- 10x Genomics' EPS (Weighted Average and Diluted) rose 6829.27% to -$0.13 in Q4 2025 from the same period last year, while for Dec 2025 it was -$0.35, marking a year-over-year increase of 7712.42%. This contributed to the annual value of -$0.35 for FY2025, which is 7697.37% up from last year.
- As of Q4 2025, 10x Genomics' EPS (Weighted Average and Diluted) stood at -$0.13, which was up 6829.27% from -$0.22 recorded in Q3 2025.
- 10x Genomics' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.28 during Q2 2025, with a 5-year trough of -$0.79 in Q3 2023.
- Over the past 5 years, 10x Genomics' median EPS (Weighted Average and Diluted) value was -$0.31 (recorded in 2024), while the average stood at -$0.3.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 47000.0% in 2022, then skyrocketed by 18750.0% in 2025.
- Over the past 5 years, 10x Genomics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.17 in 2021, then rose by 11.76% to -$0.15 in 2022, then crashed by 173.33% to -$0.41 in 2023, then grew by 0.0% to -$0.41 in 2024, then soared by 68.29% to -$0.13 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.13 for Q4 2025, versus -$0.22 for Q3 2025 and $0.28 for Q2 2025.